ucts that may be biologically useful. Iriomoteolide 1a (1)
is one of the molecules of interest because of its unique
molecular structure, potent cytotoxicity, and unknown
mode of action.4
Scheme 1. Synthesis of 6
We planned to develop a convergent and flexible route
that would allow efficient preparation of iriomoteolide 1a
and its analogues for biological studies. As shown in
Figure 1, synthesis of the six-membered cyclic hemiketal
to double bond migration to give rise to the thermodynami-
cally more stable R,ꢀ-unsaturated aldehydes. Indeed, oxida-
tion of 56 under a variety of conditions (Jone’s, PDC, Swern,
IBX, etc.) generated R,ꢀ-unsaturated aldehyde 7 as the only
product. While the combination of CrO3 and pyridine7 turned
out to be marginally useful and gave rise to a mixture of 6
and 7 (∼3:1, 70% overall), we decided to search for an
alternative route because of the low efficiencies involved in
both the preparation of 5 and the oxidation step. We resorted
to oxidative cleavage of the vicinal diol derived from 86 by
LiAlH4 reduction to synthesize 6. Oxidative cleavage of the
diol with NaIO4 again gave rise to a mixture of 6 and 7 (∼1:
2) under standard conditions.8 Fortunately, we discovered
during reaction optimization that the double bond migration
can be suppressed by addition of 0.4 equiv of acetic acid,
and the ꢀ,γ-unsaturated aldehyde 6 was isolated as the only
product under these conditions. Aldehyde 6 can be stored at
-20 °C for at least four months without significant rear-
rangement or decomposition.
With aldehyde 6 in hand, we sought to use a catalytic,
enantioselective, vinylogous aldol reaction to efficiently
install the C5-C8 fragment.9 We were pleased to find
that the coupling of 6 and the ethyl crotonate-derived silyl
dienolate 9 was effected under the Lewis base catalyzed,
Lewis acid mediated conditions developed by Denmark
with S,S-bisphosphoramide I as a chiral ligand (Scheme
2).10 The coupled product 10 was generated in 72% yield
with >95% enantiomeric excess. The absolute configu-
ration of the newly generated C9 stereocenter was assigned
as S by analogy to that reported for this catalytic system.10
The secondary hydroxyl group in 10 was protected as the
p-methoxybenzyl ether, and the resulting ester 11 was converted
to aldehyde 12 by DIBAL-H reduction and PCC oxidation.
Figure 1. Retrosynthetic analysis.
would employ a late-stage intramolecular nucleophilic
cyclization of an allylmetal species derived from allyl
chloride 2.5 The macrocycle of 2 in turn can be prepared
by sequential inter- and intramolecular esterifications of
two subunits (3 and 4) of comparable complexity. We
report herein the successful synthesis of 4 using a strategy
based on sequential application of catalytic asymmetric
vinylogous aldol reactions.
The synthesis started from preparation of aldehyde 6
(Scheme 1). Aldehydes with ꢀ,γ-unsaturation are susceptible
(6) (a) Mikami, K.; Ohmura, H.; Yamanaka, M. J. Org. Chem. 2002,
68, 1081. (b) Mikami, K.; Shimizu, M.; Nakai, T. J. Org. Chem. 1991, 56,
2952.
(7) Sanchez, C. C.; Keck, G. E. Org. Lett. 2005, 7, 3053.
(8) Wee, A. G.; Slobodian, J. Encyclopedia of Reagents for Organic
Synthesis; Paquette, L. A., Ed.; John Wiley and Sons: New York, NY, 1995;
Vol. 7, pp 4613-4616.
(4) Amphidinolide H, a member of this class of natural products, has
been shown to target Actin: (a) Saito, S.-Y.; Feng, J.; Kira, A.; Kobayashi,
J.; Ohizumi, Y. Biochem. Biophys. Res. Commun. 2004, 320, 961. (b) Usui,
T.; Kazami, S.; Dohmae, N.; Mashimo, Y.; Kondo, H.; Tsuda, M.; Terasaki,
A. G.; Ohashi, K.; Kobayashi, J.; Osada, H. Chem. Biol. 2004, 11, 1269.
However, its molecular structure is very different from that of iriomoteolide
1a.
(9) (a) Denmark, S. E.; Heemstra, J. R., Jr.; Beutner, G. L. Angew.
Chem., Int. Ed. 2005, 44, 4682. (b) Casiraghi, G.; Zanardi, F. Chem. ReV.
2000, 100, 1929.
(10) (a) Denmark, S. E.; Beutner, G. L. Angew. Chem., Int. Ed. 2008,
47, 1560. (b) Denmark, S. E.; Beutner, G. L.; Wynn, T.; Eastgate, M. D.
J. Am. Chem. Soc. 2005, 127, 3774. (c) Denmark, S. E.; Beutner, G. L.
J. Am. Chem. Soc. 2003, 125, 7800.
(5) For examples: (a) Heumann, L. V.; Keck, G. E. Org. Lett. 2007, 9,
1951. (b) Smith, A. B., III; Razler, T. M.; Meis, R. M.; Pettit, G. R. Org.
Lett. 2006, 8, 797.
4646
Org. Lett., Vol. 10, No. 20, 2008